ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 137 filers reported holding ANAPTYSBIO INC in Q4 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $261,122 | +4.4% | 8,426 | -13.9% | 0.00% | 0.0% |
| Q3 2022 | $250,000 | +4.2% | 9,786 | +0.7% | 0.00% | – |
| Q1 2022 | $240,000 | -42.2% | 9,716 | -18.6% | 0.00% | -100.0% |
| Q4 2021 | $415,000 | +22.4% | 11,936 | -4.5% | 0.00% | 0.0% |
| Q3 2021 | $339,000 | +4.6% | 12,504 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $324,000 | +44.0% | 12,504 | +19.6% | 0.00% | – |
| Q1 2021 | $225,000 | -5.9% | 10,452 | -5.9% | 0.00% | – |
| Q4 2020 | $239,000 | +45.7% | 11,102 | 0.0% | 0.00% | – |
| Q3 2020 | $164,000 | -33.9% | 11,102 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $248,000 | -71.1% | 11,102 | -81.7% | 0.00% | -66.7% |
| Q1 2020 | $858,000 | +376.7% | 60,745 | +447.2% | 0.00% | – |
| Q4 2019 | $180,000 | -53.6% | 11,102 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $388,000 | -35.8% | 11,102 | +3.7% | 0.00% | -50.0% |
| Q2 2019 | $604,000 | -18.5% | 10,707 | +5.5% | 0.00% | 0.0% |
| Q1 2019 | $741,000 | +16.1% | 10,147 | +1.4% | 0.00% | 0.0% |
| Q4 2018 | $638,000 | -31.5% | 10,007 | +7.2% | 0.00% | 0.0% |
| Q3 2018 | $931,000 | +40.4% | 9,333 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $663,000 | -27.1% | 9,333 | +6.9% | 0.00% | 0.0% |
| Q1 2018 | $909,000 | +53.8% | 8,733 | +49.0% | 0.00% | 0.0% |
| Q4 2017 | $591,000 | – | 5,863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |